Bionano Genomics, Inc.
BNGO · NASDAQ
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Bionano Genomics (BNGO) is a biotechnology company focused on developing and commercializing its advanced genomic platform. This platform enables the study of the structure and variations of the human genome with high accuracy and detail. Bionano Genomics aims to provide tools for genetic research, genetic disease diagnostics, and personalized medicine. Bionano Genomics stock is suitable for investors interested in the biotechnology sector and innovative technologies in the field of genetics. Add Bionano Genomics stock to your watchlist on Bulios and stay informed about the latest advancements in genomics and biotechnology.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Albert A. Luderer
Employees
96
Headquarters
San Diego
Upcoming events
Earnings
Upcoming earnings report